Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jul. 28, 2012	Jul. 30, 2011
Net Cash Provided by (Used for) Operating Activities	$ 205	$ 223
Investing Activities:
Capital Expenditures	(329)	(162)
Proceeds from Sale of Express Common Stock	0	99
Investment In Equity Affiliates	11
Proceeds from Divestiture of Businesses		99
Other Investing Activities	11	0
Net Cash Used for Investing Activities	(318)	(63)
Financing Activities:
Proceeds from Issuance of Long-term Debt, Net of Issuance Costs	985	981
Financing Costs	0	(7)
Repurchase of Common Stock	(604)	(890)
Dividends Paid	(146)	(431)
Excess Tax Benefits from Share-based Compensation	100	34
Net Financing Activities and Advances to/from Consolidated Affiliates	0	0
Proceeds from Exercise of Stock Options and Other	36	55
Net Cash Provided by (Used for) Financing Activities	371	(258)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	3
Net Decrease in Cash and Cash Equivalents	258	(95)
Cash and Cash Equivalents, Beginning of Period	935	1,130
Cash and Cash Equivalents, End of Period	1,193	1,035
Parent Company [Member]
Net Cash Provided by (Used for) Operating Activities	(204)	(94)
Investing Activities:
Capital Expenditures	0	0
Investment In Equity Affiliates	0
Proceeds from Divestiture of Businesses		0
Net Cash Used for Investing Activities	0	0
Financing Activities:
Proceeds from Issuance of Long-term Debt, Net of Issuance Costs	985	981
Financing Costs		(7)
Repurchase of Common Stock	(604)	(890)
Dividends Paid	(146)	(431)
Excess Tax Benefits from Share-based Compensation	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates	(67)	386
Proceeds from Exercise of Stock Options and Other	36	55
Net Cash Provided by (Used for) Financing Activities	204	94
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Decrease in Cash and Cash Equivalents	0	0
Cash and Cash Equivalents, Beginning of Period	0	0
Cash and Cash Equivalents, End of Period	0	0
Guarantor Subsidiaries [Member]
Net Cash Provided by (Used for) Operating Activities	293	205
Investing Activities:
Capital Expenditures	(184)	(88)
Investment In Equity Affiliates	8
Proceeds from Divestiture of Businesses		0
Net Cash Used for Investing Activities	(176)	(88)
Financing Activities:
Proceeds from Issuance of Long-term Debt, Net of Issuance Costs	0	0
Financing Costs		0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	81	28
Net Financing Activities and Advances to/from Consolidated Affiliates	54	(281)
Proceeds from Exercise of Stock Options and Other	0	0
Net Cash Provided by (Used for) Financing Activities	135	(253)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Decrease in Cash and Cash Equivalents	252	(136)
Cash and Cash Equivalents, Beginning of Period	371	701
Cash and Cash Equivalents, End of Period	623	565
Non-Guarantor Subsidiaries [Member]
Net Cash Provided by (Used for) Operating Activities	116	112
Investing Activities:
Capital Expenditures	(145)	(74)
Investment In Equity Affiliates	3
Proceeds from Divestiture of Businesses		99
Net Cash Used for Investing Activities	(142)	25
Financing Activities:
Proceeds from Issuance of Long-term Debt, Net of Issuance Costs	0	0
Financing Costs		0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	19	6
Net Financing Activities and Advances to/from Consolidated Affiliates	13	(105)
Proceeds from Exercise of Stock Options and Other	0	0
Net Cash Provided by (Used for) Financing Activities	32	(99)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	3
Net Decrease in Cash and Cash Equivalents	6	41
Cash and Cash Equivalents, Beginning of Period	564	429
Cash and Cash Equivalents, End of Period	570	470
Consolidation, Eliminations [Member]
Net Cash Provided by (Used for) Operating Activities	0	0
Investing Activities:
Capital Expenditures	0	0
Investment In Equity Affiliates	0
Proceeds from Divestiture of Businesses		0
Net Cash Used for Investing Activities	0	0
Financing Activities:
Proceeds from Issuance of Long-term Debt, Net of Issuance Costs	0	0
Financing Costs		0
Repurchase of Common Stock	0	0
Dividends Paid	0	0
Excess Tax Benefits from Share-based Compensation	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates	0	0
Proceeds from Exercise of Stock Options and Other	0	0
Net Cash Provided by (Used for) Financing Activities	0	0
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Net Decrease in Cash and Cash Equivalents	0	0
Cash and Cash Equivalents, Beginning of Period	0	0
Cash and Cash Equivalents, End of Period	$ 0	$ 0